Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study (NCT06347796)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to test in moderately symptomatic chronic subdural hematoma (CSDH) patients if middle meningeal artery embolization (MMAE) can be used as an alternative to conventional open surgery. The main questions it aims to answer are: * Compared to open conventional surgery, does MMAE reduce the need for rescue surgery or deaths? * What is the safety of MMAE and conventional open surgery in these patients? Participants will be asked to: * Share their medical history and undergo physical examinations * Have blood drawn * Have CT scans of the head * Answer questionnaires * Undergo MMAE or conventional open surgery * Provide information about possible adverse events Researchers will compare participants in the MMAE group with those in the conventional open surgery group to see if there is a reduced need for rescue surgery or deaths and evaluate safety.
Who can join: Review the eligibility criteria below.
Location: Mayo Clinic Arizona — Phoenix, Arizona
Age range: 40 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (31 Sites)
Showing the first 25 of 31 sites.
- Mayo Clinic Arizona — Phoenix, Arizona
- Baptist Medical Center Jacksonville — Jacksonville, Florida
- University of Miami Miller School of Medicine — Miami, Florida
- University of South Florida — Tampa, Florida
- Emory University — Atlanta, Georgia
- University of Kansas Medical Center — Kansas City, Kansas
- Massachusetts General Hospital — Boston, Massachusetts
- Brigham and Women's Hospital — Boston, Massachusetts
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Minnesota — Minneapolis, Minnesota
- University of Missouri Healthcare — Columbia, Missouri
- Washington University, St. Louis — St Louis, Missouri
- Cooper University Hospital — Camden, New Jersey
- JFK Neuroscience Institute, JFK University Medical Center — Edison, New Jersey
- Rutgers, The State University of New Jersey — Newark, New Jersey
- Ichan School of Medicine at Mount Sinai — New York, New York
- SUNY Upstate Medical University — Syracuse, New York
- Montefiore Medical Center — The Bronx, New York
- Westchester Medical Center — Valhalla, New York
- Wake Forest University — Winston-Salem, North Carolina
- Good Samaritan Hospital — Cincinnati, Ohio
- Mercy Health St. Vincent Medical Center — Toledo, Ohio
- University of Pennyslvania — Philadelphia, Pennsylvania
- Philadelphia Neurological Institute — Upland, Pennsylvania
- UT Southwestern Medical Center — Dallas, Texas
📞 Contact the Study Coordinator
Phone: (409) 266-8859
Email: jlspahn@utmb.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Subdural Hematoma
- Management of CSDH With or Without EMMA- a Randomized Control Trial — Winnipeg, Manitoba
- Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy — Valhalla, New York
- Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization — Sioux Falls, South Dakota
- Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH) — Coral Gables, Florida
- The CHALLENGER Registry — New York, New York
- Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas — Burlington, Massachusetts
Explore by condition: All Chronic Subdural Hematoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.